Imeik Technology Development's (SHE:300896) attributable profit fell 30% to 789.5 million yuan in the first half from 1.12 billion yuan in the year-ago period, according to a Tuesday filing with the Shenzhen bourse.
Earnings per share at the biomedical products manufacturer declined 30% to 2.62 yuan from 3.72 yuan in the prior-year period.
Operating income decreased 22% to 1.30 billion yuan from 1.66 billion yuan in the year-ago period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments